Quick-commerce platforms like Blinkit and Zepto are now delivering prescription medicines in under 10 minutes. While convenient, experts warn this trend bypasses safeguards under the Drugs and Cosmetics Act, raising risks of antibiotic misuse, poor verification, and spurious drugs. Chemists’ associations and doctors are urging stricter regulation to protect public health.
India’s booming quick-commerce sector has extended its reach into healthcare, with platforms such as Blinkit and Zepto offering 10-minute medicine deliveries. Though marketed as life-saving convenience, public health experts caution that speed may come at the cost of safety.
The Drugs and Cosmetics Act prohibits sale of prescription drugs without proper licensing and oversight. Yet, in practice, digital platforms often bypass verification protocols, raising concerns about antibiotic resistance, misbranded drugs, and lack of pharmacist supervision.
Chemists’ associations have already flagged the practice as illegal, urging the Union Health Ministry to intervene. Doctors warn that unchecked access could normalize self-medication and worsen India’s already critical antibiotic resistance crisis.
Major Takeaways
Convenience vs Risk: 10-minute deliveries prioritize speed over medical safeguards.
Legal Concerns: Violates provisions of the Drugs and Cosmetics Act.
Health Risks: Antibiotic misuse, spurious drugs, and poor verification processes.
Industry Pushback: Chemists’ bodies demand regulation and stricter oversight.
Expert Warning: Doctors highlight long-term dangers of self-medication and resistance.
Conclusion
While instant medicine delivery appeals to consumers, experts argue India must balance accessibility with regulation. Without robust safeguards, the promise of convenience could undermine public health, making this a critical moment for policymakers to act.
Sources: NDTV, Indian Express, CNBCTV18.